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Abstract
Background: The European Influenza Surveillance Scheme (EISS) has collected clinical and virological data on 
influenza since l996 in an increasing number of countries. The EISS dataset was used to characterise important 
epidemiological features of influenza activity in Europe during eight winters (l999-2007). The following questions 
were addressed: l) are the sentinel clinical reports a good measure of influenza activity? 2) how long is a typical 
influenza season in Europe? 3) is there a west-east and/or south-north course of peak activity ('spread') of 
influenza in Europe?
Methods: Influenza activity was measured by collecting data from sentinel general practitioners (GPs) and 
reports by national reference laboratories. The sentinel reports were first evaluated by comparing them to the 
laboratory reports and were then used to assess the timing and spread of influenza activity across Europe during 
eight seasons.
Results: We found a good match between the clinical sentinel data and laboratory reports of influenza collected 
by sentinel physicians (overall match of 72% for +/- l week difference). We also found a moderate to good match 
between the clinical sentinel data and laboratory reports of influenza from non-sentinel sources (overall match of 
60% for +/- l week). There were no statistically significant differences between countries using ILI (influenza-like 
illness) or ARI (acute respiratory disease) as case definition. When looking at the peak-weeks of clinical activity, 
the average length of an influenza season in Europe was l5.6 weeks (median l5 weeks; range l2 - l9  weeks). 
Plotting the peak weeks of clinical influenza activity reported by sentinel GPs against the longitude or latitude of 
each country indicated that there was a west-east spread of peak activity (spread) of influenza across Europe in 
four winters (200l-2002, 2002-2003, 2003-2004 and 2004-2005) and a south-north spread in three winters 
(200l-2002, 2004-2005 and 2006-2007).
Conclusion: We found that: l) the clinical data reported by sentinel physicians is a valid indicator of influenza 
activity; 2) the length of influenza activity across the whole of Europe was surprisingly long, ranging from l2 - l9  
weeks; 3) in 4 out of the 8 seasons, there was a west-east spread of influenza, in 3 seasons a south-north spread; 
not associated with type of dominant virus in those seasons.
Open Access
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Background
Influenza has an im portant impact on societies each sea­
son. Surveillance data not only provide valuable informa­
tion on the burden of disease in the population [1,2 ], but 
also enables an assessment of whether the vaccine is a 
good match with the circulating virus [3,4]. Surveillance 
may help to plan and allocate health care resources and is 
im portant for pandemic preparedness [5]. In addition, the 
surveillance infrastructure can be used to m onitor new 
emerging respiratory diseases, like SARS or avian influ­
enza in humans [6 ]. Countries in Europe have shared 
detailed clinical and virological data via the European 
Influenza Surveillance Scheme (EISS) since 1996 [7]. This 
collaborative project is partially funded by the European 
Commission through the European Centre of Disease Pre­
vention and Control (ECDC) and currently includes 30 
countries. The scheme covers a total population of about 
450 million inhabitants and an area of roughly 12 million 
square kilometres. EISS collects two types of data on influ­
enza activity each season: 1) clinical and virological data 
collected by sentinel GPs and 2 ) virological data from 
non-sentinel sources. In the present study the EISS dataset 
was used to characterise im portant epidemiological fea­
tures of influenza activity in Europe during eight winters 
(1999-2007).
In recent seasons there have been indications that influ­
enza activity first appeared in the west of Europe and then 
moved east across Europe. As an example, during the 
2003-2004 season, activity began in Ireland, the United 
Kingdom, Portugal and Spain in early August and reached 
Poland in February 2004 [8 ]. These observations led us to 
assess three related questions:
1. Are the sentinel clinical reports a good measure of influ­
enza activity?
2. How long is a typical influenza season in Europe?
3. Is there a west-east spread and/or south-north spread of 
influenza in  Europe?
Methods
General
Data from a median of 17 (14-28) countries from the 
EISS database were analysed for eight influenza seasons: 
1999-2000 (14 countries); 2000-2001 (15 countries); 
2001-2002 (16 countries); 2002-2003 (17 countries); 
2003-2004 (22 countries); 2004-2005 (22 countries); 
2005-2006 (22 countries) and 2006-2007 (28 coun­
tries). Countries were included in the analysis if they were 
at least 5 years active member of EISS and if weekly data 
were available for the full season. The assessment of influ­
enza activity presented in this paper is largely based on 
data reported by sentinel GPs. The GPs report clinical
cases of influenza-like illness (ILI) and/or acute respira­
tory infection (ARI) to a central registry and take respira­
tory specimens that are sent to a national reference 
laboratory for testing. This ensures that the clinical data 
reported by the sentinel physicians are validated by viro- 
logical data on influenza. The national reference laborato­
ries also report laboratory test results on non-sentinel 
respiratory specimens e.g. specimens from hospitals or 
non-sentinel physicians. These data were collected to have 
an additional indicator of influenza activity and to vali­
date the sentinel virological data. The national reference 
laboratories participate in the 'Community Network of 
Reference Laboratories for Human Influenza in Europe' 
(CNRL), which is coordinated by EISS [9]. CNRL works 
closely with the WHO through its network of National 
Influenza Centres and collaborates with the Centre for 
Reference and Research on Influenza at Mill Hill, London, 
UK.
In the current study only the time points of highest clini­
cal and virological activity were used, because only peak 
levels represent undisputable markers of activity in a given 
country. The reason not to take whole incidence curves 
into account is that incidence rates in Europe vary consid­
erably, because: 1) case definitions are not yet harmo­
nised across Europe; most countries report cases of ILI, but 
some report cases of ARI, 2) the denominator calculations 
vary by country and, 3) consultation rates for ILI and ARI 
vary among countries. They not only depend on cultural 
factors, bu t also on the delivery of health care. For exam­
ple, in some European countries a doctor's certificate is 
required for a single day of absence from work (leading to 
a higher consultation rate), whilst in others a certificate is 
only required after absence of 5 days or more, leading to 
a lower consultation rate.
The weeks of peak activity were selected by plotting the 
clinical and virological data available for each country. If 
the clinical and virological activity was very low during a 
season (e.g. below or around the baseline level; defined as 
level of influenza activity in the period when no influenza 
virus was detected), it was difficult to identify the peak 
week and no peak was selected. Most countries reported 
cases of ILI to EISS (13 out of the 17 countries); four coun­
tries used the less restrictive case definition of ARI (Czech 
Republic, France, Germany and Romania). Since 2004 the 
Czech Republic and Romania also report cases of ILI [10]. 
The case definitions of ILI and ARI have been described by 
EISS and discussed by Aguilera et al. [11,12]. Briefly; the 
general criteria for ILI are: sudden onset of fever > 38°C, 
with respiratory (i.e. cough, sore throat) and systemic 
symptoms (headache, muscular pain); the criteria for ARI 
are: sudden onset of respiratory symptoms, accompanied 
by fever and headache in the absence of other diagnosis.
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Validity analysis
For the validity analysis of sentinel reports, we defined a 
good match as a situation where the sentinel and virolog­
ical peaks occurred in the same week, or when there was a 
difference of only one week. For example the peak of the 
incidence of ILI consultations in the Netherlands during 
the 2002-2003 season was week 10 and the peak of posi­
tive laboratory reports of the dom inant influenza virus 
was week 9. This difference of 1 week was considered to 
be a good match. Therefore, a time difference between 
peaks of 1 week or less was taken as a measure for a good 
match (irrespective of which peak presented first); a differ­
ence of 2 weeks was taken as a reasonable match and a 
longer period as a poor match. The analysis was based on 
the percentage of countries fulfilling the criteria of a good 
or moderate match during 8 influenza seasons. In a sec­
ond validity analysis, using similar criteria, the sentinel 
clinical incidences were compared with non-sentinel lab­
oratory reports. Because the case definitions of ILI and ARI 
differ considerably, the validity analyses were performed 
separately for countries using ILI (n = 13) and countries 
using ARI criteria (n = 4). Differences in matching percent­
ages between ILI and ARI were statistically evaluated using 
the Chi-square test or Fisher exact test if the expected value 
in one of the cells was less than five.
Length o f influenza season
The length of an influenza season was roughly calculated 
by subtracting the earliest and latest week of peak clinical 
activity across Europe for each season. Per season the 
aggregated data of participating countries were used. 
Knowing that using peak weeks as indicator for activity 
would lead to underestimation of the length of the epi­
demic, because periods of high activity at the beginning 
and the end were not taken into account, 4 weeks were 
added: 2 weeks before the earliest peak and 2 weeks after 
the last peak. These periods still represent a rather conserv­
ative estimate of the slopes of increased activity around 
the incidence peaks. Eight countries participated through­
out the 8 seasons (their longitudes ranging from -4 to 
15.3); 6 countries during 7 seasons (longitudes -8 to 19.3) 
and 14 countries were included during less than 7 seasons 
(longitudes -3 to 25).
Spread o f influenza (course o f peak activity across Europe)
The sequence of peak activity of influenza in the various 
European countries was taken as a measure for the spread 
of influenza across Europe. We are well aware that the use 
of the word 'spread' is based on the liberal assumption 
that the sequence of peak activity across Europe parallels 
the actual spread of influenza. Therefore, as we have no 
clear insight into the dynamics of influenza between 
countries, in the present study 'spread' should be appreci­
ated with some caution and in a very general context. In 
order to assess a possible west-east spread or a south-
north spread of influenza activity in Europe, the peak 
week data of influenza activity in  EISS countries were plot­
ted against the longitude and latitude of the central point 
in each country. For the purpose of finding the appropri­
ate geographic centre of a country, rounded longitude and 
latitude figures were used, based on The Gazetteer of Con­
ventional Names, third Edition, August 1988 [13]. For 
Northern Ireland, Scotland, Wales and England such cen­
tral points were not available. Therefore we took the capi­
tal cities of these regions: Belfast, Edinburgh, Cardiff and 
London as best substitutes. Considering it was difficult to 
identify a peak during seasons of low influenza activity, 
the sentinel virological data, if available, were used to 
select the peak. If no sentinel virological data were availa­
ble, no peak was selected.
Regression analysis and analysis of significance was per­
formed using SPSS 11.5. The variance was expressed as 
squared correlation coefficients (R2), interpreted as fol­
lows: < 0.1 very weak correlation; 0.1-0.25 weak; 0.25­
0.50 moderate; 0.5-0.75 strong; 0.75-0.9 very strong; >
0.9 exceptionally strong correlation.
Results 
Validity analysis
Table 1 presents the clinical data in 17 countries during 
eight seasons. When using the norm  of +/- 1 week, the 
mean total overlap of sentinel clinical and virological data 
was 72% (median 71%; range 25%-100%) for countries 
using ILI as case definition, and 71% (median 73%; range 
57%-83%) for countries using ARI as case definition. 
When using the norm  of +/- 2 weeks, the mean overlap for 
ILI-countries rose to 84% (median 86%; range 50% - 
100%) and rose to 85% (median 86%; range 71%-100%) 
for countries using ARI as case definition.
Table 1 also compares the sentinel clinical data with the 
non-sentinel virological data. When using a match of +/-
1 week, the mean overlap of sentinel clinical and non-sen­
tinel virological data for countries using ILI was 63% 
(median 67%; range 0%-100%), and 46% (median 50%; 
range 43%-50%) for countries using ARI. When accepting 
a match of +/- 2 weeks, the overlap rose to 84% for ILI 
(median 86%; range 50%-100%), and to 68% for ARI 
(median 60%; range 50%-100%). The differences 
between ILI and ARI were statistically no t significant (1- 
week match, p = 0.26; 2-week match, p = 0.19).
Length of epidemic and dominant virus
Table 2 provides an indication of the length of each influ­
enza season in Europe. They ranged from 12 weeks in the 
1999-2000 season to 19 weeks in the 2003-2004 season 
(mean 15.6 weeks; median 15 weeks).
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T a b le  1: C o m p a ris o n  b e tw e e n  c lin ica l and  v iro lo g ic a l pe ak  inc idences o f  IL I and A R I d u r in g  e ig h t in flu e n z a  seasons in E u ro p e  (1 999­
2007)
S. c lin ic a l vs. S. v iro lo g ic a l S. c lin ica l vs. S. v iro lo g ic a l S. c lin ica l vs. N S . v iro lo g ic a l S. c lin ica l vs. N S . v iro lo g ic a l
IL I A R I IL I A R I
1 week overlap 72% 71% 63% 46%
2 weeks overlap 84% 85% 84% 68%
S: Sentinel, in form ation provided by sentinel general practitioners
NS: Non-sentinel, data obtained from  non-sentinel physicians, hospitals and institu tions
ILI: influenza-like illness used as case definition by 13 countries
ARI: acute resp ira to ry disease used as case definition by 4 countries
1 week overlap: occurrence o f peak incidences differ 1 w eek o r  less (good match)
2 week overlap: occurrence o f peak incidences differ 2 weeks o r  less (m oderate match)
Percentages represent the mean overall match aggregated from  data o f m ost participating countries obtained during 8 influenza seasons
The dom inant viruses (viruses most frequently identified 
in specimens) in Europe during the eight seasons were: 
influenza A(H3N2) in 1999-2000; influenza A(H1N1) 
and B in 2000-2001; A(H3N2) and B in 2001-2002; 
A(H3N2) and B in 2002-2003; A(H3N2) in 2003-2004; 
A(H3N2) in 2004-2005; influenza B, A(H3N2) and 
A(H1N1) in 2005-2006 and A(H3N2) in 2006-2007.
No correlation was found between length of the epidemic 
and type of virus or virus combinations.
also the case during the 1999-2000 and 2006-2007 sea­
sons, in which there was no indication for a west-east 
spread. We repeated the analysis for the latitudes of each 
country and found a moderate correlation in three season, 
favouring a south-north spread. During two of these sea­
sons (2001-2002 and 2004-2005) there was also a clear 
west-east spread of influenza. Taking all eight seasons into 
account the overall indication for a west-east spread was 
twice as strong than for a south-north spread (mean R2 
west-east: 0.277; mean R2 south-north: 0.137).
Course o f peak activity across Europe
Table 2 assesses the west-east and south-north spread of 
influenza activity in Europe after respectively plotting the 
longitude and latitude of each country to the peak clinical 
level of activity for each season. As an example the plot of 
the 2003-2004 season is shown in Figure 1. The assess­
m ent was based on calculation of the squared correlation 
coefficient. In four consecutive seasons (2001-2005), 
there was a moderate to strong correlation between longi­
tude and peak influenza activity, indicating a west-east 
spread of influenza. It is noteworthy that during these four 
seasons A(H3) was the dom inant virus. However, this was
Discussion
In the present study routinely collected surveillance data 
were used to assess the timing, length and spread of influ­
enza activity in Europe during eight winter seasons. It first 
tried to establish the validity of the sentinel reports and 
then used these data to assess the length of an average sea­
son in Europe and whether or not there is a general west­
east spread of influenza activity.
Validity o f  sentinel reports
The analysis in this paper is largely based on clinical sen­
tinel reports and it was therefore im portant to validate this
T a b le  2: D u ra t io n , sp read  and d o m in a n t v iruse s  in E u ro p e  d u r in g  e ig h t in flu e n z a  seasons (1 999 -200 7 )
S eason D u ra t io n W -E  (R 2) S -N  (R 2) D o m in a n t  v iru s (e s )* *
1999-2000 12 weeks 0.073 0.058 A (H 3N 2)
2000-2001 18 weeks 0.016 0.013 A (H IN I) /B
2001-2002 15 weeks 0 .3 3 1 * 0 .4 8 1 * A (H 3N 2)/B
2002-2003 15 weeks 0 .4 2 8 * 0.005 A (H 3N 2)/B
2003-2004 19 weeks 0 .5 9 8 * 0.001 A (H 3N 2)
2004-2005 18 weeks 0 .6 8 0 * 0 .2 5 0 * A (H 3N 2)
2005-2006 14 weeks 0.032 0.002 A (H 3N 2) A (H IN I )  B
2006-2007 14 weeks 0.060 0.287 A (H 3N 2)
Spread o f influenza based on analysis o f peak levels o f clinical activity 
W -E: W est-East spread; S-N: S outh -N orth  spread
R2: squared corre la tion coefficient (0.250; 0.331; 0.428; 0.481: moderate corre lation; 0.598 and 0.680: strong corre lation) 
*P < 0.05
**: virus (sub)types are only listed if they represented > 20% o f to ta l detections
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Figure!
Evidence of West-East spread of influenza in Europe during the 2003-2004 season: the longitude of 23 countries correlated 
against the peak week of influenza activity per country.
data source, first with the virological sentinel data and 
then with non-sentinel laboratory data. We found that the 
data were valid, irrespective of whether ILI or ARI was 
used as case definition. There was an overall match of 
72% (+/- 1 week) between the clinical and virological sen­
tinel data and a 60% match (+/- 1 week) between sentinel 
clinical data and the non-sentinel virological data. Allow­
ing a larger overlap (+/- 2 weeks) provided a match of 
84% and 80%, respectively. The results indicate that the 
sentinel system is very adequate in estimating influenza 
activity in a continent, irrespective of case definition. The 
strength of the system is that it combines community- 
based clinical and virological data and also can provide 
age-specific data. The sentinel approach has already been 
implemented in other continents, our results imply that it 
should be considered in other parts of the world [14].
It is no t surprising that there was a close relationship 
between the clinical and virological sentinel data. This 
relationship should be close, because the diagnosis of ILI 
or ARI and the subsequent collection of respiratory speci­
mens is done by the same person (sentinel GP). Sampling 
of specimens is also usually at its highest during the 
period of increased influenza activity, which will lead to
increased numbers of positive specimens. Some of the 
non-matches of sentinel data occurred during the Christ­
mas/New Year period when the clinical and virological 
surveillance systems are affected by holidays.
The second comparison we performed was between the 
sentinel clinical and the non-sentinel virological data. 
This was an im portant validity check because two inde­
pendent surveillance systems were compared. Many coun­
tries (e.g. the U.S.) do not collect sentinel virological data, 
bu t base the virological assessment of influenza activity 
solely on data from non-sentinel sources [15]. Our study 
found a good match between sentinel clinical and non­
sentinel virological sources. Again, the clinical rates can 
sometimes be unreliable during seasons when activity is 
very low, which may lead to mismatches. On the other 
hand, a large outbreak in a major hospital or region may 
be another im portant factor that can affect the non-senti­
nel data. Such localized outbreaks may lead to increased 
non-sentinel reports that are not picked up by the sentinel 
clinical reports, resulting in a mismatch. Taken together, 
we do favour the sentinel collection of virological data 
because the approach is more systematic, less prone to
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pre-selection and differs less among countries than clini­
cal sampling.
Length o f  an average season
The mean length of a typical influenza season in Europe 
based on the peak activity levels of ILI/ARI was 15.6 
weeks. It is a conservative estimate, because it does not 
include the period of increased influenza activity. If this 
period is also taken into account the average European 
influenza season lasts about 4.5 months. This is a impor­
tant finding as it highlights the fact that influenza activity 
occurs for a long period of time in Europe each season. It 
also highlights the need to present country-specific data, 
in order to get insight into the diversity of activity [16].
Course o f peak activity (spread) across Europe
Because the spread of influenza depends of many factors 
one might not expect a particular pattern. Still, four out of 
eight seasons showed a clear west-east spread of influenza. 
In three seasons there was a south-north spread. The over­
all indication for a west-east spread was stronger than for 
a south-north spread, which means that a west-east spread 
of influenza is a more common, but far from consistent 
phenom enon in Europe. It is noteworthy that the west­
east spread occurred in 4 consecutive seasons during 
which the more virulent A(H3) was the dom inant virus. It 
should be noted that the data for 1999-2000 and 2000­
2001  were not complete: a num ber of important countries 
to the east of Europe (Latvia, Lithuania, the Slovak Repub­
lic and Poland) were no t included in the analysis because 
data were not available. This might have affected our west­
east analysis.
In an analysis of the spread of influenza in the US over 30 
years, Viboud et al. observed a consistent early onset of 
the epidemic in California, which is the most populous 
state in the U.S. [17]. Interestingly, the onset in California 
was earlier than in 3 populous Eastern states, suggesting 
that in addition to population factors also geographical 
and climate factors, such as:, m ountain ranges, plains, 
lakes, and predominant wind direction may drive early 
epidemic activity. Some of these factors may be involved 
in a west-east spread in Europe: the western of Europe is 
the most populated part and factors that contribute to 
spread, such as commuting and airline travel conse­
quently are more intense in the western than in the east­
ern part of Europe [18].
We have used a rather crude m ethod to assess the geo­
graphic spread of influenza activity in Europe. A more 
refined m ethod would be to collect doctor specific data as 
routinely is done in France [19]. As these data are not 
available yet within EISS we had to use the methodology 
of analysing peak levels of activity in each country. In 
2005 EISS initiated a European Mapping Project, in which
data from Germany and the Netherlands were brought 
together to map the spread of influenza on a weekly basis, 
using data from about 500 physicians in Germany and 84 
in the Netherlands [20]. This project has now been 
extended to 7 countries and hopefully the upcoming data 
will allow us to better assess the spread of influenza [2 1 ]. 
These results have im portant consequences for public 
health: it allows better planning of health care resources at 
a local level, and at a European level better recommenda­
tions can be made about the timing of vaccination.
Conclusion
Our analysis has demonstrated that the sentinel clinical 
data, the main indicator used to measure influenza activ­
ity in Europe, is a valid indicator for influenza activity. We 
also found that the length of influenza activity in Europe 
was surprisingly long. Finally, during 4 out of 8 seasons 
there was a clear indication of a west-east spread and in 3 
seasons a moderate indication of a south-north spread of 
influenza activity across Europe.
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